AUPH logo

Aurinia Pharmaceuticals Inc. (AUPH) EBIT

Annual EBIT:

$14.07M+$97.38M(+116.89%)
December 31, 2024

Summary

  • As of today, AUPH annual earnings before interest & taxes is $14.07 million, with the most recent change of +$97.38 million (+116.89%) on December 31, 2024.
  • During the last 3 years, AUPH annual EBIT has risen by +$194.23 million (+107.81%).
  • AUPH annual EBIT is now at all-time high.

Performance

AUPH EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHincome statement metrics

Quarterly EBIT:

$30.67M+$1.23M(+4.18%)
September 30, 2025

Summary

  • As of today, AUPH quarterly earnings before interest & taxes is $30.67 million, with the most recent change of +$1.23 million (+4.18%) on September 30, 2025.
  • Over the past year, AUPH quarterly EBIT has increased by +$14.35 million (+87.93%).
  • AUPH quarterly EBIT is now at all-time high.

Performance

AUPH Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHincome statement metrics

TTM EBIT:

$97.10M+$14.35M(+17.34%)
September 30, 2025

Summary

  • As of today, AUPH TTM earnings before interest & taxes is $97.10 million, with the most recent change of +$14.35 million (+17.34%) on September 30, 2025.
  • Over the past year, AUPH TTM EBIT has increased by +$112.81 million (+718.33%).
  • AUPH TTM EBIT is now at all-time high.

Performance

AUPH TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

AUPH EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+116.9%+87.9%+718.3%
3Y3 Years+107.8%+412.7%+183.9%
5Y5 Years+118.5%+170.9%+183.7%

AUPH EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+107.8%at high+201.3%at high+183.9%
5Y5-Yearat high+107.8%at high+161.0%at high+153.9%
All-TimeAll-Timeat high+107.8%at high+161.0%at high+153.9%

AUPH EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
$30.67M(+4.2%)
$97.10M(+17.3%)
Jun 2025
-
$29.44M(+5.9%)
$82.75M(+57.4%)
Mar 2025
-
$27.81M(+203.1%)
$52.58M(+273.6%)
Dec 2024
$14.07M(+116.9%)
$9.18M(-43.8%)
$14.07M(+189.6%)
Sep 2024
-
$16.32M(+2332.8%)
-$15.70M(+65.6%)
Jun 2024
-
-$731.00K(+93.2%)
-$45.64M(+29.5%)
Mar 2024
-
-$10.70M(+48.1%)
-$64.71M(+22.3%)
Dec 2023
-$83.31M(+26.3%)
-$20.60M(-51.3%)
-$83.31M(+10.4%)
Sep 2023
-
-$13.62M(+31.2%)
-$92.98M(-4.3%)
Jun 2023
-
-$19.80M(+32.4%)
-$89.17M(+15.7%)
Mar 2023
-
-$29.29M(+3.2%)
-$105.84M(+6.3%)
Dec 2022
-$112.99M(+37.3%)
-$30.27M(-208.6%)
-$112.99M(+2.4%)
Sep 2022
-
-$9.81M(+73.1%)
-$115.71M(+25.9%)
Jun 2022
-
-$36.47M(-0.0%)
-$156.20M(+6.9%)
Mar 2022
-
-$36.45M(-10.5%)
-$167.84M(+6.8%)
Dec 2021
-$180.16M(-84.8%)
-$32.99M(+34.4%)
-$180.16M(-20.5%)
Sep 2021
-
-$50.30M(-4.6%)
-$149.48M(-5.0%)
Jun 2021
-
-$48.10M(+1.4%)
-$142.41M(-17.6%)
Mar 2021
-
-$48.77M(-2012.3%)
-$121.11M(-24.2%)
Dec 2020
-$97.48M(-28.2%)
-$2.31M(+94.7%)
-$97.48M(+16.0%)
Sep 2020
-
-$43.23M(-61.3%)
-$116.07M(-19.8%)
Jun 2020
-
-$26.80M(-6.6%)
-$96.85M(-12.0%)
Mar 2020
-
-$25.14M(-20.3%)
-$86.51M(-13.5%)
Dec 2019
-$76.02M(-35.4%)
-$20.90M(+13.0%)
-$76.25M(-8.9%)
Sep 2019
-
-$24.01M(-45.9%)
-$70.01M(-16.5%)
Jun 2019
-
-$16.45M(-10.5%)
-$60.11M(-3.6%)
Mar 2019
-
-$14.88M(-1.5%)
-$58.00M(-3.3%)
Dec 2018
-$56.16M(-19.3%)
-$14.66M(-3.9%)
-$56.16M(-4.7%)
Sep 2018
-
-$14.11M(+1.6%)
-$53.63M(-0.6%)
Jun 2018
-
-$14.34M(-9.9%)
-$53.32M(-8.8%)
Mar 2018
-
-$13.05M(-7.5%)
-$49.03M(-4.2%)
Dec 2017
-$47.06M(-106.3%)
-$12.14M(+12.0%)
-$47.06M(-9.6%)
Sep 2017
-
-$13.79M(-37.2%)
-$42.95M(-24.3%)
Jun 2017
-
-$10.05M(+9.3%)
-$34.55M(-18.9%)
Mar 2017
-
-$11.09M(-38.1%)
-$29.05M(-27.3%)
Dec 2016
-$22.81M(+3.2%)
-$8.03M(-48.9%)
-$22.81M(-12.3%)
Sep 2016
-
-$5.39M(-18.4%)
-$20.31M(+4.9%)
Jun 2016
-
-$4.55M(+6.1%)
-$21.35M(+6.6%)
Mar 2016
-
-$4.85M(+12.3%)
-$22.85M(+3.1%)
Dec 2015
-$23.58M(-34.6%)
-$5.52M(+14.1%)
-$23.58M(-2.7%)
Sep 2015
-
-$6.43M(-6.2%)
-$22.96M(-11.0%)
Jun 2015
-
-$6.05M(-8.5%)
-$20.68M(-7.7%)
Mar 2015
-
-$5.58M(-13.8%)
-$19.19M(-9.4%)
Dec 2014
-$17.52M(-323.7%)
-$4.90M(-18.1%)
-$17.54M(-22.6%)
Sep 2014
-
-$4.15M(+9.2%)
-$14.31M(-28.1%)
Jun 2014
-
-$4.57M(-16.4%)
-$11.17M(-48.3%)
Mar 2014
-
-$3.93M(-135.2%)
-$7.53M(-70.0%)
Dec 2013
-$4.14M(+26.6%)
-$1.67M(-65.1%)
-$4.43M(+44.6%)
Sep 2013
-
-$1.01M(-8.9%)
-$8.00M(+8.8%)
Jun 2013
-
-$928.00K(-12.6%)
-$8.77M(+14.5%)
Mar 2013
-
-$824.00K(+84.3%)
-$10.26M(-77.5%)
Dec 2012
-$5.63M(+16.0%)
-$5.24M(-194.4%)
-$5.78M(-185.0%)
Sep 2012
-
-$1.78M(+26.3%)
-$2.03M(-42.7%)
Jun 2012
-
-$2.42M(-166.1%)
-$1.42M(-55.8%)
Mar 2012
-
$3.66M(+345.6%)
-$911.30K(+85.1%)
Dec 2011
-$6.71M
-$1.49M(-26.9%)
-$6.10M(+8.0%)
DateAnnualQuarterlyTTM
Sep 2011
-
-$1.17M(+38.5%)
-$6.63M(+3.2%)
Jun 2011
-
-$1.91M(-24.7%)
-$6.85M(-23.2%)
Mar 2011
-
-$1.53M(+24.3%)
-$5.56M(-18.1%)
Dec 2010
-$4.90M(+40.4%)
-$2.02M(-45.2%)
-$4.71M(-17.0%)
Sep 2010
-
-$1.39M(-125.3%)
-$4.02M(+4.5%)
Jun 2010
-
-$617.40K(+8.9%)
-$4.21M(+28.5%)
Mar 2010
-
-$677.80K(+49.2%)
-$5.89M(+25.3%)
Dec 2009
-$8.23M(+52.8%)
-$1.33M(+15.6%)
-$7.88M(+19.8%)
Sep 2009
-
-$1.58M(+31.2%)
-$9.83M(+16.4%)
Jun 2009
-
-$2.30M(+13.8%)
-$11.76M(+21.7%)
Mar 2009
-
-$2.67M(+18.7%)
-$15.03M(+15.0%)
Dec 2008
-$17.42M(+47.1%)
-$3.28M(+6.4%)
-$17.67M(+24.3%)
Sep 2008
-
-$3.51M(+36.9%)
-$23.34M(+15.3%)
Jun 2008
-
-$5.56M(-4.7%)
-$27.54M(+12.3%)
Mar 2008
-
-$5.31M(+40.6%)
-$31.41M(+5.0%)
Dec 2007
-$32.94M(-34.6%)
-$8.95M(-16.0%)
-$33.06M(-6.4%)
Sep 2007
-
-$7.72M(+18.2%)
-$31.07M(-3.9%)
Jun 2007
-
-$9.44M(-35.5%)
-$29.91M(-12.8%)
Mar 2007
-
-$6.97M(-0.2%)
-$26.53M(-8.3%)
Dec 2006
-$24.47M(+14.7%)
-$6.95M(-6.0%)
-$24.49M(+3.6%)
Sep 2006
-
-$6.56M(-8.4%)
-$25.41M(+2.2%)
Jun 2006
-
-$6.05M(-22.7%)
-$25.97M(+2.6%)
Mar 2006
-
-$4.93M(+37.3%)
-$26.68M(+7.9%)
Dec 2005
-$28.68M(-42.7%)
-$7.87M(-10.4%)
-$28.97M(-1.4%)
Sep 2005
-
-$7.12M(-5.4%)
-$28.56M(-2.7%)
Jun 2005
-
-$6.76M(+6.4%)
-$27.82M(-11.4%)
Mar 2005
-
-$7.22M(+3.2%)
-$24.98M(-18.1%)
Dec 2004
-$20.10M(-94.1%)
-$7.46M(-16.8%)
-$21.14M(-13.5%)
Sep 2004
-
-$6.38M(-63.1%)
-$18.63M(-14.3%)
Jun 2004
-
-$3.91M(-15.5%)
-$16.30M(-52.5%)
Mar 2004
-
-$3.39M(+31.5%)
-$10.69M(-2.3%)
Dec 2003
-$10.36M(-578.7%)
-$4.95M(-22.0%)
-$10.45M(-21.6%)
Sep 2003
-
-$4.06M(-338.4%)
-$8.59M(-209.5%)
Jun 2003
-
$1.70M(+154.1%)
-$2.78M(-23.8%)
Mar 2003
-
-$3.14M(-1.6%)
-$2.24M(-53.5%)
Dec 2002
-$1.53M(+82.4%)
-$3.09M(-275.7%)
-$1.46M(-203.4%)
Sep 2002
-
$1.76M(-21.2%)
$1.41M(+156.6%)
Jun 2002
-
$2.23M(+194.6%)
-$2.50M(+68.1%)
Mar 2002
-
-$2.36M(-982.9%)
-$7.83M(-3.0%)
Dec 2001
-$8.65M(-35.1%)
-
-
Dec 2001
-
-$218.20K(+89.9%)
-$7.61M(-3.0%)
Sep 2001
-
-$2.15M(+30.7%)
-$7.39M(-41.1%)
Jun 2001
-
-$3.10M(-45.3%)
-$5.24M(-145.3%)
Mar 2001
-
-$2.14M(>-9900.0%)
-$2.14M(>-9900.0%)
Dec 2000
-$6.40M(-223.8%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2000
-
$0.00(0.0%)
$0.00(+100.0%)
Jun 2000
-
$0.00(0.0%)
-$397.40K(0.0%)
Mar 2000
-
$0.00(0.0%)
-$397.40K(+38.9%)
Nov 1999
-$1.98M(+18.8%)
$0.00(+100.0%)
-$650.40K(0.0%)
Aug 1999
-
-$397.40K(>-9900.0%)
-$650.40K(-157.1%)
May 1999
-
$0.00(+100.0%)
-$253.00K(0.0%)
Feb 1999
-
-$253.00K(>-9900.0%)
-$253.00K(>-9900.0%)
Nov 1998
-$2.43M
-
-
Nov 1998
-
$0.00(0.0%)
$0.00(0.0%)
Aug 1998
-
$0.00(0.0%)
$0.00(0.0%)
May 1998
-
$0.00(0.0%)
$0.00(0.0%)
Feb 1998
-
$0.00
$0.00

FAQ

  • What is Aurinia Pharmaceuticals Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. annual EBIT year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. quarterly EBIT year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. TTM EBIT year-on-year change?

What is Aurinia Pharmaceuticals Inc. annual earnings before interest & taxes?

The current annual EBIT of AUPH is $14.07M

What is the all-time high annual EBIT for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high annual earnings before interest & taxes is $14.07M

What is Aurinia Pharmaceuticals Inc. annual EBIT year-on-year change?

Over the past year, AUPH annual earnings before interest & taxes has changed by +$97.38M (+116.89%)

What is Aurinia Pharmaceuticals Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of AUPH is $30.67M

What is the all-time high quarterly EBIT for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high quarterly earnings before interest & taxes is $30.67M

What is Aurinia Pharmaceuticals Inc. quarterly EBIT year-on-year change?

Over the past year, AUPH quarterly earnings before interest & taxes has changed by +$14.35M (+87.93%)

What is Aurinia Pharmaceuticals Inc. TTM earnings before interest & taxes?

The current TTM EBIT of AUPH is $97.10M

What is the all-time high TTM EBIT for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high TTM earnings before interest & taxes is $97.10M

What is Aurinia Pharmaceuticals Inc. TTM EBIT year-on-year change?

Over the past year, AUPH TTM earnings before interest & taxes has changed by +$112.81M (+718.33%)
On this page